A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine.
Moderate to high levels of regular physical activity are associated with lower lung function decline among smokers and help to moderate their risk of developing chronic obstructive pulmonary disease (COPD), according to a large retrospective cohort study.
Primary graft dysfunction, a common compliction that affects up to 25 percent of lung transplant patients shortly after surgery, constitutes a significant risk factor for later deadly bronchiolitis obliterans syndrome (BOS).
A study published in the March 1 issue of the journal Sleep finds that people with obstructive sleep apnea (OSA) are at an increased risk of having cardiovascular disease.
A study published in the March 1 issue of the journal Sleep finds that sleepy near-misses may be dangerous precursors to an actual accident.
A study published in the March 1 issue of the journal Sleep finds that, as opposed to treating insomnia, failure to treat it is much more costly.
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine.
Pfizer Animal Health (PAH) announced the U.S. Food and Drug Administration (FDA) has approved Cerenia(TM) (maropitant citrate), the first medication to prevent and treat acute vomiting in dogs.
Sweat may be another way to pass on hepatitis B infection during contact sports, suggests research published ahead of print in the British Journal of Sports Medicine.
Even as the AIDS epidemic in Los Angeles County has shifted largely to Hispanics, primary-care practitioners serving this segment of the population often fail to offer either HIV testing or safer sex advice to their patients, according to a new UCLA AIDS Institute study